Hospitals that switched C. diff testing from nonmolecular to molecular methods recorded a 56 percent increase in recorded C. diff cases after the change, according to an article published in Infection Control and Hospital Epidemiology.
Read the full article onBecker's Hospital Review.
More Articles on Quality:
Read the full article onBecker's Hospital Review.